Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Russian vaccine can deal with mutations

Russian vaccine can deal with mutations

A Russian trial testing the effectiveness of revaccination with the Sputnik V shot to protect against new mutations of the coronavirus is producing strong results, researchers have said. Last month President Vladimir Putin ordered a review by March 15 of Russian-produced vaccines for their effectiveness against new variants spreading in different parts of the world. "(A) recent study carried out by the Gamaleya Centre in Russia showed that revaccination with Sputnik V vaccine is working very well against new coronavirus mutations, including the UK and South African strains of coronavirus," said Denis Logunov, a deputy director of the centre, which…
Read More
Russia tests one-dose ‘light’ in UAE, Ghana

Russia tests one-dose ‘light’ in UAE, Ghana

POLINA NIKOLSKAYA and EMILIO PARODI RUSSIAN developers of the Sputnik V vaccine against COVID-19 have applied for domestic approval of a single-dose "light" version, and that trials of it in Russia, the United Arab Emirates and Ghana have already begun. The slimmed-down shot is not expected to be as effective as the original vaccine, said Arsen Kubataev, of the Russian Direct Investment Fund, the sovereign wealth fund marketing the vaccine abroad. But the outlook for it is "optimistic", he said. RDIF has previously suggested the one-shot version of Sputnik V could be a "temporary" solution for countries with high infections…
Read More
Q&A: Where are we in the COVID-19 vaccine race?

Q&A: Where are we in the COVID-19 vaccine race?

LARGE global trials of several COVID-19 vaccine candidates involving tens of thousands of participants are well underway with some having gathered sufficient data to seek emergency use authorisation. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.45 million lives worldwide: Who is furthest along? U.S. drugmaker Pfizer Inc and German partner BioNTech SE released a full late-stage trial data analysis on Nov. 18 that showed their shot was 95% effective at stopping COVID-19, the highest efficacy rate so far. U.S. pharmaceutical company Moderna released its…
Read More
Egypt receives first batch of Sinopharm coronavirus vaccines

Egypt receives first batch of Sinopharm coronavirus vaccines

EGYPT has received its first shipment of vaccines developed by China National Pharmaceutical Group (Sinopharm) and will get more deliveries soon, health officials have disclosed. The shipment arrived at Cairo airport from the United Arab Emirates, which has been carrying out phase III clinical trials of the vaccine. The UAE health ministry said this week that the Sinopharm vaccine had 86% efficacy, citing an interim analysis of the late-stage clinical trials. The vaccine has already been used on about 1 million people in China in an emergency programme. In Egypt the vaccine, taken in two doses 21 days apart, will…
Read More
Algeria launches coronavirus vaccination campaign

Algeria launches coronavirus vaccination campaign

ALGERIA yesterday launched a coronavirus vaccination campaign, a day after receiving its first shipment of Russia's Sputnik V vaccine, the government said. The campaign started in the Blida province, 40 km (25 miles) southwest of the capital, Algiers, where the country's first confirmed cases of the coronavirus were reported last March. Algeria received 50,000 doses of Sputnik V on Friday, said Djamel Fourar, head of the Scientific Committee in charge of dealing with the pandemic. The North African country will receive a shipment of the AstraZeneca vaccine on Sunday, Communication Minister Ammar Belhimer said, without providing the number of doses.…
Read More
Ghana approves Russia’s vaccine

Ghana approves Russia’s vaccine

Russia's RDIF sovereign wealth fund has announced that Ghana had granted emergency authorisation for the use of the Sputnik V vaccine against COVID-19, becoming the 31st country to do so, and the fifth African state. The Russian vaccine was approved by the West African country's health ministry, the Russian Direct Investment Fund said in a statement.
Read More
Russia offers 300 million doses

Russia offers 300 million doses

ALEXANDER WINNING and JOE BAVIER  THE African Union's (AU) vaccine task team has disclosed that Russia had offered it 300 million doses of its Sputnik V COVID-19 vaccine along with a financing package for countries wanting to secure the shots. The Russian vaccine will be available for a period of 12 months starting May 2021, it said in a statement. The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said some deliveries could start in May but most would be from June. The 55-member AU hopes to see 60% of the continent's 1.3 billion people…
Read More